Inspire Medical Systems EPS - Earnings per Share 2017-2024 | INSP
Inspire Medical Systems annual and quarterly earnings per share history from 2017 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Inspire Medical Systems EPS for the quarter ending September 30, 2024 was $0.60, a 306.9% decline year-over-year.
- Inspire Medical Systems EPS for the twelve months ending September 30, 2024 was $1.09, a 200% decline year-over-year.
- Inspire Medical Systems 2023 annual EPS was $-0.72, a 55% decline from 2022.
- Inspire Medical Systems 2022 annual EPS was $-1.6, a 3.9% increase from 2021.
- Inspire Medical Systems 2021 annual EPS was $-1.54, a 29.68% decline from 2020.
| Inspire Medical Systems Annual EPS | |
|---|---|
| 2023 | $-0.72 |
| 2022 | $-1.60 |
| 2021 | $-1.54 |
| 2020 | $-2.19 |
| 2019 | $-1.40 |
| 2018 | $-1.50 |
| 2017 | $-14.88 |
| 2016 | $-16.90 |
| Inspire Medical Systems Quarterly EPS | |
|---|---|
| 2024-09-30 | $0.60 |
| 2024-06-30 | $0.32 |
| 2024-03-31 | $-0.34 |
| 2023-12-31 | $0.51 |
| 2023-09-30 | $-0.29 |
| 2023-06-30 | $-0.41 |
| 2023-03-31 | $-0.53 |
| 2022-12-31 | $0.14 |
| 2022-09-30 | $-0.60 |
| 2022-06-30 | $-0.53 |
| 2022-03-31 | $-0.61 |
| 2021-12-31 | $-0.08 |
| 2021-09-30 | $-0.38 |
| 2021-06-30 | $-0.48 |
| 2021-03-31 | $-0.60 |
| 2020-12-31 | $-0.25 |
| 2020-09-30 | $-0.39 |
| 2020-06-30 | $-0.88 |
| 2020-03-31 | $-0.67 |
| 2019-12-31 | $-0.39 |
| 2019-09-30 | $-0.34 |
| 2019-06-30 | $-0.32 |
| 2019-03-31 | $-0.35 |
| 2018-12-31 | $4.20 |
| 2018-09-30 | $-0.22 |
| 2018-06-30 | $-0.43 |
| 2018-03-31 | $-5.05 |
| 2017-12-31 | $-3.42 |
| 2017-09-30 | $-3.42 |
| 2017-06-30 | $-4.14 |
| 2017-03-31 | $-3.90 |
| 2016-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.669B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hims & Hers Health (HIMS) | United States | $5.506B | 140.00 |
| Tempus AI (TEM) | United States | $5.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.799B | 0.00 |
| Enovis (ENOV) | United States | $2.475B | 16.78 |
| Privia Health (PRVA) | United States | $2.357B | 196.40 |
| Azenta (AZTA) | United States | $2.286B | 122.05 |
| Omnicell (OMCL) | United States | $2.053B | 67.15 |
| 10x Genomics (TXG) | United States | $1.718B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.568B | 0.00 |
| Schrodinger (SDGR) | United States | $1.486B | 0.00 |
| Phreesia (PHR) | United States | $1.464B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.846B | 0.00 |
| Standard BioTools (LAB) | United States | $0.651B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.563B | 0.00 |
| Talkspace (TALK) | United States | $0.529B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.476B | 82.40 |
| Health Catalyst (HCAT) | United States | $0.446B | 0.00 |
| TruBridge (TBRG) | United States | $0.297B | 86.52 |
| Pulmonx (LUNG) | United States | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| CareCloud (CCLD) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Precipio (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |